Masimo | MASI - Operating Profit


Masimo reported $83.6M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Accuray USD 4.71M 6.86M Dec/2024
Align Technology USD 224.71M 40.06M Dec/2025
AngioDynamics USD -9.97M 1.12M Feb/2025
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
General Electric Aerospace USD 1.77B 536M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD -84.62M 65.72M Dec/2024
Owens Minor USD 56.75M 56.63M Jun/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025